Taani -
taani -
Lægemiddelstyrelsen (Danish Medicines Agency)
epoprostenol "campuspharma" 1,5 mg pulver og solvens til infusionsvæske, opløsning
campuspharma ab - epoprostenolnatrium - pulver og solvens til infusionsvæske, opløsning - 1,5 mg
Taani -
taani -
Lægemiddelstyrelsen (Danish Medicines Agency)
epoprostenol "campuspharma" 500 mikrogram pulver og solvens til infusionsvæske, opløsning
campuspharma ab - epoprostenolnatrium - pulver og solvens til infusionsvæske, opløsning - 500 mikrogram
Taani -
taani -
Lægemiddelstyrelsen (Danish Medicines Agency)
salofalk 1 g rektalskum
dr. falk pharma gmbh - mesalazin - rektalskum - 1 g
Taani -
taani -
Lægemiddelstyrelsen (Danish Medicines Agency)
salofalk 1 g suppositorier
dr. falk pharma gmbh - mesalazin - suppositorier - 1 g
Taani -
taani -
Lægemiddelstyrelsen (Danish Medicines Agency)
dacepton 5 mg/ml infusionsvæske, opløsning
ever neuro pharma gmbh - apomorphinhydrochlorid hemihydrat - infusionsvæske, opløsning - 5 mg/ml
Taani -
taani -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxylan depot 10 mg depottabletter
g.l. pharma gmbh - oxycodonhydrochlorid - depottabletter - 10 mg
Taani -
taani -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxylan depot 20 mg depottabletter
g.l. pharma gmbh - oxycodonhydrochlorid - depottabletter - 20 mg
Taani -
taani -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxylan depot 40 mg depottabletter
g.l. pharma gmbh - oxycodonhydrochlorid - depottabletter - 40 mg
Taani -
taani -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxylan depot 80 mg depottabletter
g.l. pharma gmbh - oxycodonhydrochlorid - depottabletter - 80 mg
Euroopa Liit -
taani -
EMA (European Medicines Agency)
thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.